These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2726104)
1. GnRH analog delivery systems: present and future options. Miller JD Obstet Gynecol Surv; 1989 May; 44(5):326-9. PubMed ID: 2726104 [No Abstract] [Full Text] [Related]
2. General applications of GnRH agonists in gynecology: past, present, and future. Hodgen GD Obstet Gynecol Surv; 1989 May; 44(5):293-6. PubMed ID: 2657515 [No Abstract] [Full Text] [Related]
3. Clinical experience in the treatment of endometriosis with GnRH agonist. Hill GA Obstet Gynecol Surv; 1989 May; 44(5):305-7. PubMed ID: 2726102 [No Abstract] [Full Text] [Related]
4. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Yen SS Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985 [TBL] [Abstract][Full Text] [Related]
5. [Response to acute administration of pituitary inhibiting hormone, growth hormone and one of its analogues in acromegaly]. Gonzalez-Barcena D; Kastin AJ; Coy DH; Schalch DS; Lara-Vasconcelos M; Gonzalez-Sanchez A; Schally AV Arch Invest Med (Mex); 1975; 6(3):505-12. PubMed ID: 1190942 [No Abstract] [Full Text] [Related]
6. Clinical experience with the use of GnRH agonists in the treatment of premenstrual syndrome. Muse KN Obstet Gynecol Surv; 1989 May; 44(5):317-8. PubMed ID: 2726103 [No Abstract] [Full Text] [Related]
8. [Clinical use of the releasing hormone, formed in the hypothalamus, its agonists and antagonists]. Friedrich F Hippokrates; 1976 Nov; 47(4):362-5. PubMed ID: 794040 [No Abstract] [Full Text] [Related]
9. [Drug delivery systems by controlled release]. Nagai T Yakugaku Zasshi; 1988 Jul; 108(7):613-24. PubMed ID: 3071605 [No Abstract] [Full Text] [Related]
10. Endometriosis: pathophysiology, diagnosis, and treatment. Hurst BS; Rock JA Obstet Gynecol Surv; 1989 May; 44(5):297-304. PubMed ID: 2657516 [TBL] [Abstract][Full Text] [Related]
11. [Corticotropic function of the pituitary gland in Cushing's syndrome treated with chloditane]. Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK Ter Arkh; 1978; 50(11):72-5. PubMed ID: 214890 [No Abstract] [Full Text] [Related]
12. [Injectable and implantable drug delivery systems]. Iga T Nihon Rinsho; 1989 Jun; 47(6):1261-7. PubMed ID: 2769988 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of a novel depot formulation of abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, in healthy men ages 50 to 75. Wong SL; Lau DT; Baughman SA; Fotheringham N; Menchaca D; Garnick MB J Clin Pharmacol; 2004 May; 44(5):495-502. PubMed ID: 15102870 [TBL] [Abstract][Full Text] [Related]
14. New drugs in the treatment of pituitary disorders. Van Loon GR Prim Care; 1977 Dec; 4(4):721-37. PubMed ID: 337337 [TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys. Navot D; Rosenwaks Z; Anderson F; Hodgen GD Fertil Steril; 1991 Jun; 55(6):1069-75. PubMed ID: 1828042 [TBL] [Abstract][Full Text] [Related]
16. Assessment of pituitary response to nasal application of synthetic gonadotropin-releasing hormone in men. Potashnik G; Ben-Adereth N; Lunenfeld B; Rofe C Fertil Steril; 1977 Jun; 28(6):650-4. PubMed ID: 324823 [TBL] [Abstract][Full Text] [Related]
19. Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use. Beck LR; Pope VZ Drugs; 1984 Jun; 27(6):528-47. PubMed ID: 6376061 [TBL] [Abstract][Full Text] [Related]
20. [Risk of current methods in contraception]. Zufferey MM Rev Med Suisse Romande; 1985 Feb; 105(2):147-50. PubMed ID: 3885360 [No Abstract] [Full Text] [Related] [Next] [New Search]